2 In addition to being an age-related cerebrovascular abnormality, [3] [4] [5] CMBs are associated with dementia. The prevalence of CMBs is reported to be higher in patients with Alzheimer's disease (AD) and vascular dementia compared with the general population. 6 The mechanisms underlying CMBs and their effects on neuropsychological functions are subjects of active research.
C erebral microbleeds (CMBs) are lesions related to small hemorrhages seen as well-demarcated, hypointense, and rounded lesions on magnetic resonance imaging (MRI) sequences sensitive to magnetic susceptibility. 1 The presence of these lesions has been regarded as one of the manifestations of age-related cerebral small vessel disease (CSVD), which include lacunes and white matter hyperintensities (WMH).
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links between the presence of CMBs and their locations and cognitive function, as evaluated by an extensive neuropsychological battery in a community-based Taiwanese population.
Methods

I-Lan Longitudinal Aging Study and General Assessment
Please see online-only Data Supplement for more information.
9-11
Population of the Present Study
Subjects in the ILAS study (I-Lan Longitudinal Aging Study) who had (1) depression revealed by CES-D, (2) evidence of stroke or brain tumor as indicated by a medical history or a brain imaging study, or (3) an implant contraindicated for MRI were excluded. The study was approved by the Institutional Review Board of National Yang Ming University. All participants had provided signed informed consent.
Cognitive Function Assessment
All participants received a face-to-face neuropsychological examination performed by by trained interviewers. In addition to global cognitive performance, which was examined using the Mini-Mental State Examination (MMSE), 4 different cognitive domains (verbal memory, language ability, visuospatial executive function, and verbal executive function) were assessed using extensive neuropsychological tests as follows: 1. Verbal memory: delayed (30 seconds and 10 minutes) free recall in the Chinese Version of the Verbal Learning Test (CVVLT). 12 2. Language: category (animal) verbal fluency test. 13 3. Visuospatial executive function: the copy test of the Taylor complex figure test 14 and the clock drawing test. 15 4. Verbal executive function: digit backward test. 16 We defined global cognitive impairment as an MMSE score <24 in well-educated people (education ≥6 years) or <14 in less-educated people (education <6 years).
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Brain MRI Acquisition
Please see online-only Data Supplement information.
CMB and Other CSVDs Assessment
All images were displayed and viewed using MRIcro software (version 1.40, Chris Rorden's MRIcro) by the same neurologist (Dr Chung), who was blind to the subjects' clinical data during CMBs assessment. CMBs were defined as small, rounded, or circular, well-defined hypointense lesions within brain parenchyma with clear margins and a size of ≤10 mm on the susceptibility weighted imaging image. 8, 19 Microbleed mimics such as vessels, calcification, partial volumes, air-bone interfaces, and hemorrhages within or adjacent to an infarct were carefully excluded. We used the Microbleed Anatomic Rating Scale 19 to measure the presence, amount, and topographical distributions of CMBs in each subject. Microbleeds were categorized as deep, lobar, or infratentorial. Lobar topography was determined according to Stark and Bradley 20 and included cortical and subcortical regions (including subcortical U fibers). Lobar CMBs were assessed in the frontal, parietal, temporal, and occipital regions. Deep regions included the basal ganglia (BG), the thalamus, the internal capsule, the external capsule, the corpus callosum, and the deep/periventricular white matter. Infratentorial regions included the brain stem and the cerebellum. Deep/periventricular white matter was defined as white matter adjacent to or within ≈10 mm of the lateral ventricular margin. CMBs in 20 random-sampled subjects' images were evaluated again at a separate time, and the intrarater k was 0.83 (95% confidence interval 0.79-0.90). We also reassessed CMBs in 25 random-sampled subjects' images by Dr Chung and the other investigator. The inter-rater k was 0.82 (95% confidence interval 0.79-0.88).
Characteristics of the other manifestations of CSVD, including lacune numbers and WMH severity, were also recorded for every subject using FLAIR-T2-weighted MRI. Lacunes are small CSF-containing cavities, which are smaller than 15 mm in diameter and are located in deep gray or white matter with adjacent WMH. 8 The severity of WMH was rated using the modified Fazekas scale, 21 which scores 0 as no WMH, 1 as mild WMH, 2 as moderate WMH, and 3 as severe WMH.
Statistical Analysis
Analyses were performed using SAS software, version 9. 
Evaluation of CMBs and Other CSVDs (Lacunes and WMH)
The prevalence, numbers, and topographical distributions of CMBs are listed in Table 1 . CMBs were found in 136 (14.2%) of the subjects. Among them, most (83, 8.7%) had only one lesion, 54 (5.6%) subjects had ≥2 CMBs, 16 (1.7%) had ≥5 CMBs, and 5 (0.5%) had ≥10 CMBs. Most CMBs, both in terms of prevalence and number, were found in deep brain regions (75 subjects, 7.8%). Infratentorial and lobar CMBs were found in 26 subjects (2.7%) and 69 subjects (7.2%), respectively. There were 85 subjects (8.8%) with DI CMBs, and 49 subjects (5.1%) with SL CMBs. No CMBs were found in the internal capsule, the external capsule, or the corpus callosum. Assessment of other CSVDs showed that 45 (4.7%) subjects had >1 lacune and 151 (15.7%) subjects had moderate to severe WMH (Fazekas scale score of 2-3).
Comparison of Basic Characteristics of Subjects With and Without CMBs
The results are shown in Table 2 . Subjects with CMBs were significantly older and had less years of education.
After adjusting for age and sex, we found no associations between cardiovascular risk factors and the presence of CMBs. There was a strong correlation between the presence of CMBs and the presence of other CSVDs. Subjects with CMBs had significantly higher lacune numbers and more severe WMHs. The results also revealed that global cognitive impairment was twice as common in the CMBpositive group than in the CMB-negative group, although this was statistically not significant. 
The Presence of CMBs and Cognition
CMB Locations and Cognition
The relationship between the location of the CMBs and cognition was also validated using multivariate linear regression analyses ( Table 3 ). The results indicate that there is no association between DI CMBs and cognitive function. Because previous studies have shown that BG CMBs are associated with cognitive deficits, 22, 23 we tested the BG region separately. The results indicated that there is no correlation between BG CMBs and performance in any of the cognitive domains after adjusting for age, sex, and years of education (data not shown). On the contrary, subjects with SL CMBs had significant deficits in the MMSE (global cognitive function), the 10-minute delayed free recall in CVVLT (verbal memory), and the copy test of the Taylor complex figure test and the clock drawing test (visual executive function). The results indicated that SL CMBs were significantly associated with global cognitive decline (MMSE) and deficits in visual executive functions after adjusting for age, sex, years of education, cardiovascular risk factors, and other CSVDs. We also observed a trend for an association between a higher prevalence of global cognitive impairment and SL CMBs (8.2% versus 3.5%).
There were only 19 (2%) subjects who had both deep and lobar CMBs in the present study. The results showed that the group of both deep and lobar CMBs had lower scores in all cognitive domains but was not significantly associated with any (data not shown).
Discussion
The main findings of the present study, which was performed in an Asian community-based population, are that (1) the presence of CMBs was associated with deficient global cognitive functions, and (2) the locations of the CMBs are important in determining their associations with cognitive impairments. SL CMBs, but not DI CMBs, were correlated with deficits in global cognitive and visual executive functions. These associations were independent of age, sex, years of education, cardiovascular risk factors, and other CSVDs (lacunes and WMH).
Consistent with previous studies, our results revealed that executive function is linked with CMBs in the general population. 22 , 24 We also show that visuospatial, but not verbal executive functions, are associated with CMBs. Our findings are in line with the result of the Epidemiology of Dementia in Singapore Study. 25 They found that CMBs were associated with deficits in executive functions, but that only the deficits in the visuoconstruction domain reached a robust statistical significance. Visuospatial and verbal executive functions involve different neural networks. Compared with the verbal domain, the visuospatial domain is affected by external intellectual training and education, which needs more complex network processing. 26 This may explain the difference of susceptibility to cerebral microvascular lesions between verbal and visual executive domains. Other studies have also shown that agerelated cognitive decline occurs earlier and more dramatically in the visuospatial domain compared with the verbal domain and that visuospatial executive deficits usually precede typical memory impairments in the prodromal phases of dementia. 27, 28 Our results suggest that CMBs should be investigated in the context of early visuospatial ability decline in the elderly to determine whether and how CMBs are involved in the pathophysiology of such deficits.
Notably, our results also showed a significant association between SL CMBs and the 10-minute delayed free recall in CVVLT though the statistical significance was borderline after multiple adjustment, including MRI measures of other CSVDs (P=0.056). Therefore, SL CMBs might be related to neurodegenerative diseases involving recent memory, such as AD. The borderline-significant association between SL CMBs and memory domain is possibly because that our study subjects were at an early or prodromal stage of disease. A future longitudinal follow-up study will be needed to validate this postulation.
Conclusions regarding effects of CMB location on cognition in the general population are controversial. [22] [23] [24] 29, 30 Some studies report that deep CMBs, 22, 23 particularly those in the BG, are associated with cognitive decline, whereas others 29, 30 report that lobar CMBs are associated with deficits in cognitive performance, which is in line with our results. Differences in population-based cohorts may explain why deep or lobar locations of MBs appear more prominently in different studies. Because the locations of the CMBs may reflect different mechanisms of action, 3, 7, 8 distinct underlying pathologies may mediate the relationship between CMBs and cognitive impairment. CAA, a common age-related condition, is characterized by a progressive deposition of amyloid-β in the media and adventitia of arterioles, capillaries, and venules in the cerebral cortex and the gray/white matter junction. Several studies have provided evidences showing lobar CMBs as a marker of CAA. 3, 24, [31] [32] [33] The relationship between SL CMBs and cognitive function found in the present study implies that CAA might be the underlying pathology of CMB-related cognitive impairment.
Because CAA pathology is frequently observed in AD, 32, 34 the relationship between CAA, independent of AD pathology, and cognition has been a topic of debate. A recent autopsy study reported that CAA pathology is associated with an increased rate of decline in cognitive functions proximate to death (mean age at death: 88.5 years). 34 These associations were independent of AD pathology, which supports a role for CAA as an important and independent contributor to late-life cognitive impairment. CMBs of certain locations observed by imaging have been suggested as early markers of CAA. 24 The present study, performed in a relatively young and functionally preserved population, may provide clues to the cognitive influence of CAA on domains such as visuospatial executive function at early disease stages. However, further studies on correlations between neuroimaging and pathology are needed to validate the specificity of the relationship between CAAand CMB-related cognitive impairment.
Several studies have found an association between CSVDs and brain atrophy. Most were investigating the brain volume abnormalities in WMH. [35] [36] [37] [38] Some studies with small population have evaluated the relationship between CMBs and brain volume. 39, 40 One study showed that brain parenchyma fraction was inversely related to the number of CMBs in patients with cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 39 The other study of AD patients also revealed gray matter atrophy in the temporal lobe and cerebellum in patients with CAA-related CMBs. 40 Therefore, it is possible that brain atrophy plays a role in the mechanisms linking CMBs and cognitive impairment. We did not measure the brain volume in the present study. A future study to evaluate (1) the association between brain atrophy and CMBs and (2) the role of brain volume in the relationship between CMBs and cognitive impairment in the general population should be conducted to validate the postulation.
Nerve tracts, including executive functional tracts, radiate from the cortex in lobar subcortical regions. SL CMBs may influence cognitive functions by strategically damaging and disrupting the functional pathway in white matter. Neural pathway imaging, such as diffusion tensor imaging combined with advanced CMB detection using computer algorithms, will enable us to elucidate this postulated mechanism in the future.
Most Asian community-based studies have only assessed global cognitive function (eg, MMSE) to evaluate the relationship between CMBs and cognition. 23, 41, 42 The present study evaluated whether CMBs and their locations were associated with a variety of cognitive domains. In addition, we used susceptibility weighted imaging on a 3T MRI, which is a tool with better resolution and higher sensitivity, 8 to detect CMBs. We also adjusted for other CSVDs (lacune and WMH) while analyzing the relationship between CMB and cognition. Our results demonstrate the neuropsychological significance of CMBs in an Asian population and provide clues to the underlying mechanisms of CMB-related cognitive impairment. The other strength of our study is that it includes a community-based, functionally preserved study population free of stroke incidence, which enables our results to be applied to the healthy general population. We can, thus, use our results to design strategies for the future early detection of vascular cognitive impairment.
Our study has some limitations. First, the cross-sectional design could not identify causal relationships between CMBs and cognitive impairment. A longitudinal study is needed to accomplish this goal. Second, there may be factors helpful for mechanism evaluation, such as markers for AD and CAA, APOE genotype differences, which we did not evaluate in the present study. In the future, we would also need to obtain other measurements, such as brain volume, amyloid loading, inflammatory and oxidative stress markers, and neural pathway imaging (eg, diffusion tensor imaging), to elucidate the mechanisms involved in the relationship between CMBs and cognitive impairment. Last but not least, because CAA is almost found universally in AD, 32, 34 it is possible that the SL CMBs were a surrogate marker of preclinical or early stage of AD, which could account for the cognitive deficits that were identified in the present study, rather than strictly a result of CAA. The present study is not able to differentiate between the 2.
In summary, the present Asian community-based study reveals an association between CMBs and cognitive function. The locations of CMBs are important in determining the relationship between CMBs and cognition. SL CMBs are associated with deficits in global cognitive and visuospatial executive functions.
